KLAUS; Stephen J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for KLAUS; Stephen J..The latest application filed is for "methods for treating anemia in subjects having kidney failure using inhibitors of hypoxia-inducible factor (hif) hydroxylase".
Company Profile
9.33.57
- KLAUS; Stephen J. - Boston MA
- Klaus; Stephen J - Boston MA
- Klaus; Stephen J. - Clayton MO
- Klaus; Stephen J. - San Francisco MA US
- Klaus; Stephen J. - New York NY
- Klaus, Stephen J. - Seattle WA
Patent Activity
| Patent | Date |
|---|---|
| Methods For Treating Anemia In Subjects Having Kidney Failure Using Inhibitors Of Hypoxia-inducible Factor (hif) Hydroxylase App 20210369702 - KLAUS; Stephen J. ; et al. | 2021-12-02 |
| Enhanced Erythropoiesis And Iron Metabolism App 20210114987 - Klaus; Stephen J. ; et al. | 2021-04-22 |
| Enhanced Erythropoiesis And Iron Metabolism App 20210107878 - Klaus; Stephen J. ; et al. | 2021-04-15 |
| Enhanced erythropoiesis and iron metabolism Grant 10,927,081 - Klaus , et al. February 23, 2 | 2021-02-23 |
| Enhanced erythropoiesis and iron metabolism Grant 10,894,774 - Klaus , et al. January 19, 2 | 2021-01-19 |
| Enhanced erythropoiesis and iron metabolism Grant 10,882,827 - Klaus , et al. January 5, 2 | 2021-01-05 |
| Enhanced erythropoiesis and iron metabolism Grant 10,626,090 - Klaus , et al. | 2020-04-21 |
| Systems And Methods For Acount Processing Validation App 20190303930 - MILAM; AMY CHRISTINE ; et al. | 2019-10-03 |
| Systems and methods for account processing validation Grant 10,325,258 - Milam , et al. | 2019-06-18 |
| Enhanced Erythropoiesis And Iron Metabolism App 20180208558 - Klaus; Stephen J. ; et al. | 2018-07-26 |
| Enhanced Erythropoiesis And Iron Metabolism App 20180162819 - Klaus; Stephen J. ; et al. | 2018-06-14 |
| Account mask identifier apparatus, method, and computer program product Grant 9,922,311 - Milam , et al. March 20, 2 | 2018-03-20 |
| Enhanced erythropoiesis and iron metabolism Grant 9,920,011 - Klaus , et al. March 20, 2 | 2018-03-20 |
| Methods For Treating A Neurological Disorder In A Subject Using Inhibitors Of Hypoxia-inducible Factor (hif) Proyl Hydroxylase App 20170312268 - KLAUS; Stephen J. ; et al. | 2017-11-02 |
| Compounds and methods for treatment of stroke Grant 9,775,902 - Klaus , et al. October 3, 2 | 2017-10-03 |
| Enhanced Erythropoiesis and Iron Metabolism App 20170267641 - Klaus; Stephen J. ; et al. | 2017-09-21 |
| Enhanced Erythropoiesis and Iron Metabolism App 20170224673 - Klaus; Stephen J. ; et al. | 2017-08-10 |
| Enhanced Erythropoiesis and Iron Metabolism App 20170216274 - Klaus; Stephen J. ; et al. | 2017-08-03 |
| Enhanced Erythropoiesis and Iron Metabolism App 20170216248 - Klaus; Stephen J. ; et al. | 2017-08-03 |
| Enhanced Erythropoiesis and Iron Metabolism App 20150246886 - Klaus; Stephen J. ; et al. | 2015-09-03 |
| Methods For Treating Anemia In Subjects Having Kidney Failure Using Inhibitors Of Hypoxia-inducible Factor (hif) Hydroxylase App 20150080425 - KLAUS; STEPHEN J. ; et al. | 2015-03-19 |
| Systems And Methods For Account Processing Validation App 20150012423 - Milam; Amy Christine ; et al. | 2015-01-08 |
| Treatments for pancreatic cancer metastases Grant 8,865,173 - Spong , et al. October 21, 2 | 2014-10-21 |
| Account Mask Identifier Apparatus, Method, And Computer Program Product App 20140279464 - Milam; Amy C. ; et al. | 2014-09-18 |
| Enhanced Erythropoiesis and Iron Metabolism App 20140142136 - Klaus; Stephen J. ; et al. | 2014-05-22 |
| Treatments for cancer Grant 8,728,468 - Spong , et al. May 20, 2 | 2014-05-20 |
| Enhanced erythropoiesis and iron metabolism Grant 8,629,131 - Klaus , et al. January 14, 2 | 2014-01-14 |
| Enhanced erythropoiesis and iron metabolism Grant 8,614,204 - Klaus , et al. December 24, 2 | 2013-12-24 |
| Enhanced erythropoiesis and iron metabolism Grant 8,609,646 - Klaus , et al. December 17, 2 | 2013-12-17 |
| Enhanced erythropoiesis and iron metabolism Grant 8,604,013 - Klaus , et al. December 10, 2 | 2013-12-10 |
| Enhanced erythropoiesis and iron metabolism Grant 8,604,012 - Klaus , et al. December 10, 2 | 2013-12-10 |
| Compounds and methods for treatment of cancer Grant 8,530,404 - Seeley , et al. September 10, 2 | 2013-09-10 |
| Treatments for Cancer App 20130209451 - Spong; Suzanne M. ; et al. | 2013-08-15 |
| Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase App 20130203805 - Klaus; Stephen J. ; et al. | 2013-08-08 |
| Methods for improving kidney function Grant 8,318,703 - Klaus , et al. November 27, 2 | 2012-11-27 |
| Fat regulation Grant 8,202,834 - Fourney , et al. June 19, 2 | 2012-06-19 |
| Methods for improving kidney function App 20120149712 - Klaus; Stephen J. ; et al. | 2012-06-14 |
| Treatment of diabetes Grant 8,124,582 - Guenzler-Pukall , et al. February 28, 2 | 2012-02-28 |
| Compounds and Methods for Treatment of Stroke App 20110263644 - Klaus; Stephen J. ; et al. | 2011-10-27 |
| Methods For Treatment Of Multiple Sclerosis App 20110263642 - Klaus; Stephen J. ; et al. | 2011-10-27 |
| Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase App 20110166178 - Klaus; Stephen J. ; et al. | 2011-07-07 |
| Methods For Increasing Endothelial Progenitor Cells App 20110039885 - Klaus; Stephen J. ; et al. | 2011-02-17 |
| Enhanced erythropoiesis and iron metabolism App 20110039886 - Klaus; Stephen J. ; et al. | 2011-02-17 |
| Enhanced erythropoiesis and iron metabolism App 20110038950 - Klaus; Stephen J. ; et al. | 2011-02-17 |
| Methods For Increasing White Blood Cells App 20110039879 - Klaus; Stephen J. ; et al. | 2011-02-17 |
| Compounds and methods for treatment of cancer-related anemia App 20110015223 - Seeley; Todd W. ; et al. | 2011-01-20 |
| Treatment method for anemia App 20100331362 - Klaus; Stephen J. ; et al. | 2010-12-30 |
| Enhanced erythropoiesis and iron metabolism App 20100278941 - Klaus; Stephen J. ; et al. | 2010-11-04 |
| Enhanced erythropoiesis and iron metabolism App 20100280044 - Klaus; Stephen J. ; et al. | 2010-11-04 |
| Compounds and methods for treatment of chemotherapy-induced anemia App 20100204269 - Seeley; Todd W. ; et al. | 2010-08-12 |
| Fat regulation App 20100168152 - Fourney; Patrick D. ; et al. | 2010-07-01 |
| Methods For Inhibiting T Helper Cell Differentiation App 20100144737 - Chow; Felice Aisha ; et al. | 2010-06-10 |
| Compounds and methods for treatment of chemotherapy-induced anemia Grant 7,713,986 - Seeley , et al. May 11, 2 | 2010-05-11 |
| Fat regulation Grant 7,618,940 - Fourney , et al. November 17, 2 | 2009-11-17 |
| Connective Tissue Growth Factor Signaling App 20080254487 - Klaus; Stephen J. ; et al. | 2008-10-16 |
| Treatments for cancer App 20080206256 - Spong; Suzanne M. ; et al. | 2008-08-28 |
| Compounds and methods for treatment of chemotherapy-induced anemia App 20070292433 - Seeley; Todd W. ; et al. | 2007-12-20 |
| Compounds and methods for treatment of cancer-related anemia App 20070293575 - Seeley; Todd W. ; et al. | 2007-12-20 |
| Compounds and methods for treatment of stroke App 20070259960 - Klaus; Stephen J. ; et al. | 2007-11-08 |
| Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers App 20070042937 - Klaus; Stephen J. ; et al. | 2007-02-22 |
| Compounds and methods for treatment of cancer App 20070004627 - Seeley; Todd W. ; et al. | 2007-01-04 |
| Treatment method for anemia App 20060276477 - Klaus; Stephen J. ; et al. | 2006-12-07 |
| Cytoprotection through the use of hif hydroxylase inhibitors App 20060251638 - Guenzler-Pukall; Volkmar ; et al. | 2006-11-09 |
| Methods of increasing endogenous erythropoietin (EPO) App 20060183695 - Klaus; Stephen J. ; et al. | 2006-08-17 |
| Methods of increasing endogenous erythropoietin (EPO) App 20060178316 - Klaus; Stephen J. ; et al. | 2006-08-10 |
| Methods of increasing endogenous erythropoietin (EPO) App 20060178317 - Klaus; Stephen J. ; et al. | 2006-08-10 |
| Treatments for cancer App 20050271670 - Spong, Suzanne M. ; et al. | 2005-12-08 |
| Therapeutic compounds for inhibiting interleukin-12 signals and method for using same Grant 6,878,715 - Klein , et al. April 12, 2 | 2005-04-12 |
| Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same App 20050049262 - Klein, J. Peter ; et al. | 2005-03-03 |
| Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same App 20050032748 - Klein, J. Peter ; et al. | 2005-02-10 |
| Enhanced erythropoiesis and iron metabolism App 20050020487 - Klaus, Stephen J. ; et al. | 2005-01-27 |
| Fat regulation App 20040235082 - Fourney, Patrick D. ; et al. | 2004-11-25 |
| Treatment of diabetes App 20040204356 - Guenzler-Pukall, Volkmar ; et al. | 2004-10-14 |
| Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same Grant 6,774,130 - Klein , et al. August 10, 2 | 2004-08-10 |
| Hydroxyl-containing compounds Grant 6,693,105 - Underiner , et al. February 17, 2 | 2004-02-17 |
| Hydroxyl-containing compounds App 20030207901 - Underiner, Gail E. ; et al. | 2003-11-06 |
| Methods of increasing endogenous erythropoietin (EPO) App 20030153503 - Klaus, Stephen J. ; et al. | 2003-08-14 |
| Therapeutic Compounds For Inhibiting Interleukin-12 Signaling And Methods For Using Same App 20020028823 - KLEIN, J. PETER ; et al. | 2002-03-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 